Enzon Announces Reverse Stock Split
ENZON PHARMS INC (ENZN)
US:NASDAQ Investor Relations:
investor.enzon.com/investor-relations
Company Research
Source: GlobeNewswire
CRANFORD, N.J., March 24, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or the “Company”), today announced that the previously approved 1-for-100 reverse stock split will become effective on March 24, 2026, at 4:30 pm, Eastern Time (the “Effective Time”), and the Company’s common stock is expected to begin trading on a reverse stock split-adjusted basis on the OTCQB at market open on March 25, 2026. The Company’s common stock is expected to trade under the temporary symbol “ENZND” for 20 trading days. As of the Effective Time, every one hundred (100) shares of the Company’s issued and outstanding common stock will be combined into one (1) share of common stock. The par value per share of the Company’s common stock will not change. No fractional shares will be issued in connection with the reverse stock split, and stockholders who would otherwise be entitled to a fractional share will receive a proportional cash payment. The Company’s transfer agent, C
Show less
Read more
Impact Snapshot
Event Time:
ENZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ENZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ENZN alerts
High impacting ENZON PHARMS INC news events
Weekly update
A roundup of the hottest topics
ENZN
News
- Enzon Announces Completion of the Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred StockGlobeNewswire
- Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred StockGlobeNewswire
- Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred StockGlobeNewswire
- Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred StockGlobeNewswire
- Enzon Announces Extension of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred StockGlobeNewswire
ENZN
Sec Filings
- 3/25/26 - Form 425
- 3/25/26 - Form 8-K
- 3/25/26 - Form SC
- ENZN's page on the SEC website